Immune-engineered device targets chemo-resistant lymphoma
Dave Burbank/University PhotographyAnkur Singh, left, works in his lab with doctoral student Sungwoong Kim. Non-Hodgkin lymphoma, a cancer that is diagnosed in the U.S. more than 70,000 times annually, arises from overly proliferating immune cells within the body’s lymph nodes, which are connected to a network of lymph vessels through which…